Registry for individuals interested in inherited cancer predisposition
Inherited CAncer REgistry (ICARE) Initiative
Vanderbilt-Ingram Cancer Center · NCT03231891
This study is looking for people who want to learn more about inherited cancer risks and participate in research to help improve understanding and education about cancer genetics.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Vanderbilt-Ingram Cancer Center (other) |
| Locations | 1 site (Nashville, Tennessee) |
| Trial ID | NCT03231891 on ClinicalTrials.gov |
What this trial studies
The Inherited CAncer REgistry (ICARE) Initiative aims to enroll individuals who are interested in participating in studies related to inherited cancer predisposition. This observational registry collects data for various studies, including gene-specific research, and provides educational resources to participants and healthcare providers. Participants receive newsletters with updates on cancer genetics and can engage in monthly web-based case conferences led by experts in the field. The initiative fosters a collaborative environment for research and education in cancer genetics.
Who should consider this trial
Good fit: Ideal candidates for this registry are individuals aged 18 and older who are interested in inherited cancer predisposition.
Not a fit: Patients who are under 18 years of age or unable to provide informed consent may not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of inherited cancer risks and improve patient outcomes through targeted research and education.
How similar studies have performed: Other similar registries have shown success in advancing research and understanding of genetic predispositions to cancer.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * At least 18 years of age * Able and willing to provide informed consent
Where this trial is running
Nashville, Tennessee
- Vanderbilt-Ingram Cancer Center — Nashville, Tennessee, United States (RECRUITING)
Study contacts
- Principal investigator: Tuya Pal, MD — Vanderbilt University Medical Center
- Study coordinator: Anne Weidner, MPH
- Email: ICARE@vumc.org
- Phone: 615-875-2444
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cancer